P neumonia and influenza combined are the fifth leading cause of death in the United States. 1 Four million cases of pneumonia occur annually, and 20% of episodes require hospitalization. 2 The average length of stay for pneumonia in individuals aged 65 and older is 9.4 days, compared with 6.2 days for those younger than 65. 3 Mortality rates from pneumonia increase steadily with age, from a rate of 24 per 100,000 admissions for patients aged 60 to 64 to 1,032 per 100,000 admissions for those aged 85 and older. 4 Hazards of hospitalization have been well documented in older adults. 5 Functional decline occurs quickly upon hospitalization and often fails to improve after discharge. 6, 7 Recently several studies have been performed to define pathways of care for individuals with community-acquired pneumonia (CAP). Fine et al. developed a disease-severity model, the Pneumonia Prognosis Index (PPI), based on mortality. 8 However, whether this PPI and the proposed recommendations can be applied to older adults with CAP has not been specifically addressed. Age carries a significant weight in assessing the severity of illness by Fine's criteria. We applied Fine's PPI retrospectively to all veterans who were admitted with CAP over a 1-year period to assess the validity of the PPI for older adults.
METHODS

Study Population
We studied all cases of CAP in patients aged 60 and older admitted to the Ann Arbor Veterans Affairs Medical Center between January 1, 1998, and December 31, 1998. Patients were identified by admitting and discharge diagnoses from computerized records.
To be considered, individuals had to be aged 60 and older and have pneumonia defined by chest radiograph demonstrating a new infiltrate and the presence of at least two of the following symptoms and signs compatible with pneumonia: (1) new or increased cough, (2) new or increased sputum production, (3) fever of 38 Њ C or greater, (4) pleuritic chest pain, (5) new or increased physical findings on chest examination (rales, rhonchi, wheezes, bronchial breath sounds), (6) new/increased shortness of breath, (7) respiratory rate of 25 or more per minute, or (8) worsening mental or functional status. 9 Episodes that did not meet the case definition of pneumonia were excluded even if it was recorded as the principal diagnosis. We also excluded all individuals who acquired pneumonia more than 72 hours after admission to hospital.
Demographic Data and Clinical Parameters
Demographic data of age, gender, site of residence, admitting diagnosis, length of stay, medical history (abnormal mental status, fever, cough, pleuritic chest pain, falls, hemoptysis, antibiotic usage, reduced oral intake), signs on admission (temperature, heart rate, respiratory rate, blood pressure), laboratory parameters within 24 hours of admission (serum urea nitrogen, sodium, glucose, white cell count, hematocrit, partial pressure of arterial oxygen (P a O 2 ), and arterial pH), radiographic findings, complications, and outcome were recorded. The presence of preexisting comorbidities, including neoplasm, congestive heart failure (CHF), cerebrovascular disease, renal disease, liver disease, diabetes mellitus, coronary artery disease, and chronic obstructive pulmonary disease (COPD), were assessed by past medical history, medication history, and review of laboratory data. Neoplastic disease included any cancer except skin cancer that was active at the time of presentation or diagnosed within a year of presentation.
Microbiology
Microbiology data was obtained from clinical records. A significant proportion of patients (20 episodes) were admitted from outside hospitals; microbiology data on these individuals were not available.
Pneumonia Prognosis Index
The PPI by Fine et al. was utilized, and patients were classified as being in one of the five classes (see Table 1 ). Class 1 (aged Ͻ 50, no coexisting conditions, laboratory abnormalities, or physical findings), Class 2 ( Ͻ 70 points), Class 3 (71-90 points), Class 4 (90-130 points) and Class 5 ( Ͼ 130 points). 
Outcomes
The primary outcome was mortality at 30 days after the diagnosis of pneumonia. Secondary outcomes were length of stay, admission to a monitored bed, and the presence of complications from pneumonia defined by empyema, exacerbation of CHF, myocardial infarction, shock, acute respiratory distress syndrome, intubation, and metastatic infection.
Data Analysis
Data were entered in Epi-Info 6 (Version 6.04b, Centers for Disease Control, Atlanta, GA) and analyzed in SAS, version 6.12 (SAS Institute, Inc., Cary, NC). All the residents were stratified into Class 1 to 5 based on their PPI score. The unit of analysis was an episode of pneumonia, because some of the residents had more than one episode. Data were expressed as mean Ϯ standard deviation. Mean values were compared using analysis of variance. Categorical variables were compared using chi-square analysis. Kaplan-Meier analysis method was used to plot survival. Of the 93 discharged patients, only three were in Class 2, and 19 were in Class 3, of whom only one died in the follow-up period. Therefore, we focused our analysis on the patients in Classes 4 and 5.
RESULTS
Demographics
Between January 1, 1998, and December 31, 1998, 82 patients aged 60 and older with 101 episodes of CAP were admitted to the Ann Arbor VA Medical Center. The mean age was 72 Ϯ 9 (range 60-89), and 98% (n ϭ 98) were men. Although most of these patients were admitted through the emergency room, 20% (n ϭ 20) were transfers from an outside hospital and 7% (n ϭ 7) were admitted from a nursing home. For 82% of the episodes, patients were admitted to general medical wards. The mean length of stay was 7.1 Ϯ 6.0 days. The mean length intensive care unit (ICU) stay for those admitted to an ICU was 4.5 Ϯ 2.8 days. Only one patient was admitted for an extended period of 181 days and was excluded from the analysis of length of stay. Comorbidities were frequently present and included COPD, coronary artery disease, prior history of pneumonia, diabetes mellitus, smoking, and CHF (Table 2) .
Clinical Presentation
The most common presenting symptoms were reduced ambulation (45%), poor oral intake (40%), altered mental status (28%), pleurisy (20%), and tachypnea (19%). The most common presenting laboratory abnormalities were hypoxia with a P a 0 2 less than 60 mmHg (65%), a blood urea nitrogen greater than 30 mg/dl (25%), and a hematocrit less than 30% (18%). Mean white blood cell count was 13.9 Ϯ 6.5 cells/mm 3 .
Microbiology
Sputum cultures were performed in 62 episodes and showed a predominant organism in 21. The organisms isolated were Hemophilus influenzae (n ϭ 6), Klebsiella pneumoniae (n ϭ 4), Pseudomonas aeruginosa (n ϭ 3), Enterobacter aerogenes (n ϭ 3), Streptococcus pneumoniae (n ϭ 2), Staphylococcus aureus (n ϭ 2), Serratia marcescans (n ϭ 1), and Escherichia coli (n ϭ 1). Blood cultures were performed in 82 episodes but were positive in only five (6%), yielding S. aureus in two and S. intermedius , K. pneumoniae , and P. aeruginosa in one each.
PPI Index and Clinical Outcomes
Most episodes of CAP requiring admission to hospital fell in Class 3 (20/101), Class 4 (46/101), and Class 5 (32/ 101). There were no episodes in Class 1 and only three in Class 2. Of Class 3 episodes, there were no abnormalities in PPI-specific findings on physical examination; only 50% (10/20) had any comorbidities and 55% (11/20) had a PPIspecific abnormality in their laboratory or radiographic finding. Overall, a majority of episodes (75%) in Class 3 had no or only one PPI-specific abnormality; most were classified in Class 3 based on their age alone. Nineteen of 46 (42%) episodes in Class 4 did not have any comorbidities, but 31 of 32 (96%) episodes in Class 5 had one or more comorbidities. A higher PPI score was associated with a higher rate of admission to a monitored bed, either telemetry or ICU (P Ͻ .0001). With a higher PPI score there was also an increased chance of developing one or more complications of pneumonia (P Ͻ .001), the most prevalent being exacerbation of CHF (14%) and respiratory failure requiring intubation (13%). Moreover, a higher PPI class predicted a longer length of stay (P Ͻ .001). The overall in-hospital mortality was 8% (n ϭ 8 ⁄ 101). For Classes 3, 4, and 5, the 30-day mortalities were 0.5%, 10.8%, and 25.0%, respectively. Mean long-term follow-up of 13 months revealed mortalities of 1%, 33%, and 63% for PPI Classes 3, 4, and 5, respectively ( Figure 1, Table 3 ). Thus, higher PPI score was significantly associated with higher likelihood of death in hospital (8%), at 30 days (14%), and at mean long-term follow-up of 13 months (37%) (P Ͻ .001) ( Table 3) .
DISCUSSION
The PPI has been developed in an effort to address the variability in the rates of hospitalization of adults with pneumonia. 8 It is aimed at identifying patients with CAP who are at a low risk of mortality and other adverse outcomes so as to help physicians make more rational decisions about hospitalization for patients with pneumonia. In the study by Fine et al., the overall in-hospital mortality for all adults aged 18 and older in Classes 3, 4, and 5 was 0.9%, 9.3%, and 27%, respectively. Outpatient management was recommended for PPI Classes 1 and 2, a brief observation for Class 3, and traditional in-patient care for Classes 4 and 5. 8 In our study, we found that most pneumonia episodes fell into PPI Classes 3, 4, and 5.
Mortality from CAP increases steadily with age. 4, 8, [10] [11] [12] [13] [14] [15] [16] In a retrospective medical record review of Medicare patients, in-hospital mortality for PPI Classes 3, 4, and 5 was 2.8%, 8.5%, and 24.4%, respectively. 11 Twenty-three percent of this cohort was admitted from a nursing facility. In another study assessing the utility of this index for patients with nursing home acquired pneumonia, a higher PPI class predicted a poor outcome; 30-day mortality for Classes 3, 4, and 5 in this cohort was 4.8%, 12.0%, and 33.0%, respectively. 10 In our study, a higher PPI score was associated with an increased frequency of admission to a monitored bed, a higher incidence of developing one or more complications, a longer length of stay, and a higher risk of mortality. However, the in-hospital mortality was lower than these previous studies in older adults, with rates of 0.5%, 6.5%, and 12.5% for Classes 3, 4, and 5, respectively. Perhaps the better outcome can be attributed to the fact that our patients were not as old and only a few were nursing home residents. However, long-term mortality remained poor in our cohort, as shown in other studies. 14 Age is considered a major predictor of poor outcome in many illnesses, including pneumonia, and is an important component of the PPI risk classification system. In our study, almost half of the episodes designated Class 3 and Class 4 did not have any PPI-specific comorbidities. Rello et al. found that the presence of complications and the severity of illness at initial presentation were the major variables affecting outcome in older adults with severe CAP; with the exception of immunosuppression, comorbidities did not influence outcomes. 13 Given the shorter length of stay and a very low mortality, Class 3 patients may have been an appropriate target for outpatient management.
We noted only two patients with S. pneumoniae pneumonia and a greater than expected occurrence of gramnegative bacilli. Bates et al. noted that gram-negative bacilli were the causative agents of pneumonia in 12 of 154 (8%) patients, and gram-positive cocci accounted for 22 of 154 (14%). 17 These contrasts could be explained by the differences in patient population studied or methods of obtaining the etiologic agent. As in other studies, the overall yield of blood cultures remained low. 12, 13 However, our study was not designed to optimize the collection of sputum or to define the etiologic cause of pneumonia.
The practical utility of PPI remains to be determined. PPI requires diagnostic testing including renal function, electrolytes, glucose, hemoglobin, and arterial blood gas measurements. Although these tests were performed on admission for most of our patients evaluated in the emergency room, the decision for admission and the necessity for a monitored bed is usually made before some of the results are available: a situation that is even more applicable in nursing homes or outpatient clinics. In a recent study, it was demonstrated that variables usually available during initial evaluation (e.g., age, presence of a comorbid condition, altered motor response to verbal commands, an abnormal vital sign, and serum creatinine Ͼ1.5mg/dl) were independently associated with mortality in older adults. 18 A discriminant rule was developed using these variables. Other outcomes, such as length of stay, development of complications, transfer to an intensive care unit, and impairment in functional status, were not assessed. Although not within the scope of this study, it would be interesting to compare these two severity indices in a prospective fashion.
In conclusion, we found that the higher classes of PPI could accurately identity older adults at higher risk of developing complications and mortality and also predicted the individuals with a longer length of stay. However, further prospective studies are required to further define the bedside clinical findings most predictive of mortality in older adults prospectively; the relative significance of age, comorbidities, and severity at presentation; and the role of functional status on the clinical outcome from CAP.
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